Mayo Clinic Care Network Content
Articles

Asthma medications: Know your options

Biologics for eosinophilic asthma

A newer class of biologic drugs has been developed to target specific substances produced by certain immune system cells. For some people, certain white blood cells, called eosinophils, build up within body tissues. Eosinophils release substances, called cytokines, which cause inflammation. These biological drugs target eosinophils and cytokines, reducing their numbers within the body and lowering inflammation.

These medications include:

  • Benralizumab (Fasenra)
  • Dupilumab (Dupixent)
  • Mepolizumab (Nucala)
  • Reslizumab (Cinqair)